This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Scurlock, H. J. Articles by Catalan, J. Search for Related Content PubMed Articles by Scurlock, H. J. Articles by Catalan, J. Social Bookmarking                         What's this?

Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection

Psychological Medicine Unit, Charing Cross and Westminster Medical School and Mental Health Centre, Chelsea and Westminster Hospital 369 Fulham Road, London SW10 9NG, UK

Ashok N. Singh

Psychological Medicine Unit, Charing Cross and Westminster Medical School and Mental Health Centre, Chelsea and Westminster Hospital 369 Fulham Road, London SW10 9NG, UK

Jose Catalan

Psychological Medicine Unit, Charing Cross and Westminster Medical School and Mental Health Centre, Chelsea and Westminster Hospital 369 Fulham Road, London SW10 9NG, UK

We report four people with human immunodeficiency virus (HIV) infection and mania whose manic symptoms improved when given the atypical antipsychotic agent remoxipride as an adjunct, and in whom traditional neuroleptics were not well tolerated due to marked extrapyramidal side effects. General issues surrounding choice of pharmacological agent in HIV-related mania are discussed.

Key Words: HIV-1 infection • AIDS • psychosis • mania • treatment • atypical neuroleptics • case report

Journal of Psychopharmacology, Vol. 9, No. 2, 151-154 (1995)
DOI: 10.1177/026988119500900210


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?